Report Thumbnail
Product Code QY0914414488D5T
Published Date 2024/6/19
QY Research
English187 PagesGlobal

Global Veterinary Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030 ‐ Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code QY0914414488D5T◆The Jun 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/6/19
QY Research
English 187 PagesGlobal

Global Veterinary Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030 ‐ Pharmaceutical_LifeSciense Market


Abstract

Summary

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
The global Veterinary Vaccine market is projected to reach US$ 17260 million by 2030 from an estimated US$ 11540 million in 2024, at a CAGR of 6.9% during 2024 and 2030.
Global veterinary vaccine key players include Merck, Zoetis, Boehringer Ingelheim, Ceva, and others. The top three producers together account for more than 60% of the market share, with Merck being the largest producer with approximately 25%. Global origins are mainly in North America, Europe, China, India, Latin America, South America, South Korea, Japan, Turkey, Middle East, Southeast Asia, etc. In terms of their products, live attenuated vaccines have the largest market share with a 50% share, followed by inactivated vaccines. In terms of its application, farm animals are the number one target, with a 70% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine.
The Veterinary Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
RVSRI
Medion
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Other
Segment by Application
Farm Animal
Companion Animal
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Veterinary Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

Table of Contents

  • 1 Study Coverage

    • 1.1 Veterinary Vaccine Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global Veterinary Vaccine Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
      • 1.2.2 Live Attenuated Vaccines
      • 1.2.3 Inactivated Vaccines
      • 1.2.4 Other
    • 1.3 Market by Application
      • 1.3.1 Global Veterinary Vaccine Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
      • 1.3.2 Farm Animal
      • 1.3.3 Companion Animal
    • 1.4 Study Objectives
    • 1.5 Years Considered

  • 2 Executive Summary

    • 2.1 Global Veterinary Vaccine Market Size Estimates and Forecasts
      • 2.1.1 Global Veterinary Vaccine Revenue 2019-2030
      • 2.1.2 Global Veterinary Vaccine Sales 2019-2030
    • 2.2 Veterinary Vaccine Market Size by Region: 2023 Versus 2030
    • 2.3 Veterinary Vaccine Sales by Region (2019-2030)
      • 2.3.1 Global Veterinary Vaccine Sales by Region: 2019-2024
      • 2.3.2 Global Veterinary Vaccine Sales Forecast by Region (2025-2030)
      • 2.3.3 Global Veterinary Vaccine Sales Market Share by Region (2019-2030)
    • 2.4 Veterinary Vaccine Market Estimates and Projections by Region (2025-2030)
      • 2.4.1 Global Veterinary Vaccine Revenue by Region: 2019-2024
      • 2.4.2 Global Veterinary Vaccine Revenue Forecast by Region (2025-2030)
      • 2.4.3 Global Veterinary Vaccine Revenue Market Share by Region (2019-2030)

  • 3 Global Veterinary Vaccine by Manufacturers

    • 3.1 Global Top Veterinary Vaccine Manufacturers by Sales
      • 3.1.1 Global Veterinary Vaccine Sales by Manufacturer (2019-2024)
      • 3.1.2 Global Veterinary Vaccine Sales Market Share by Manufacturer (2019-2024)
    • 3.2 Global Top Veterinary Vaccine Manufacturers by Revenue
      • 3.2.1 Global Veterinary Vaccine Revenue by Manufacturer (2019-2024)
      • 3.2.2 Global Veterinary Vaccine Revenue Share by Manufacturer (2019-2024)
    • 3.3 Global Veterinary Vaccine Price by Manufacturer (2019-2024)
    • 3.4 Competitive Landscape
      • 3.4.1 Key Veterinary Vaccine Manufacturers Covered: Ranking by Revenue
      • 3.4.2 Global Veterinary Vaccine Market Concentration Ratio (CR5 and HHI) & (2019-2024)
      • 3.4.3 Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.5 Global Veterinary Vaccine Manufacturing Base Distribution, Product Type
      • 3.5.1 Veterinary Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.5.2 Manufacturers Veterinary Vaccine Product Type
      • 3.5.3 Date of International Manufacturers Enter into Veterinary Vaccine Market
    • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

  • 4 Company Profiles

    • 4.1 Merck
      • 4.1.1 Merck Company Information
      • 4.1.2 Merck Description, Business Overview
      • 4.1.3 Merck Veterinary Vaccine Products Offered
      • 4.1.4 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.1.5 Merck Veterinary Vaccine Sales by Product in 2023
      • 4.1.6 Merck Veterinary Vaccine Sales by Application in 2023
      • 4.1.7 Merck Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.1.8 Merck Recent Developments
    • 4.2 Zoetis
      • 4.2.1 Zoetis Company Information
      • 4.2.2 Zoetis Description, Business Overview
      • 4.2.3 Zoetis Veterinary Vaccine Products Offered
      • 4.2.4 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.2.5 Zoetis Veterinary Vaccine Sales by Product in 2023
      • 4.2.6 Zoetis Veterinary Vaccine Sales by Application in 2023
      • 4.2.7 Zoetis Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.2.8 Zoetis Recent Developments
    • 4.3 Boehringer Ingelheim
      • 4.3.1 Boehringer Ingelheim Company Information
      • 4.3.2 Boehringer Ingelheim Description, Business Overview
      • 4.3.3 Boehringer Ingelheim Veterinary Vaccine Products Offered
      • 4.3.4 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.3.5 Boehringer Ingelheim Veterinary Vaccine Sales by Product in 2023
      • 4.3.6 Boehringer Ingelheim Veterinary Vaccine Sales by Application in 2023
      • 4.3.7 Boehringer Ingelheim Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.3.8 Boehringer Ingelheim Recent Developments
    • 4.4 Ceva
      • 4.4.1 Ceva Company Information
      • 4.4.2 Ceva Description, Business Overview
      • 4.4.3 Ceva Veterinary Vaccine Products Offered
      • 4.4.4 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.4.5 Ceva Veterinary Vaccine Sales by Product in 2023
      • 4.4.6 Ceva Veterinary Vaccine Sales by Application in 2023
      • 4.4.7 Ceva Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.4.8 Ceva Recent Developments
    • 4.5 CAHIC
      • 4.5.1 CAHIC Company Information
      • 4.5.2 CAHIC Description, Business Overview
      • 4.5.3 CAHIC Veterinary Vaccine Products Offered
      • 4.5.4 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.5.5 CAHIC Veterinary Vaccine Sales by Product in 2023
      • 4.5.6 CAHIC Veterinary Vaccine Sales by Application in 2023
      • 4.5.7 CAHIC Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.5.8 CAHIC Recent Developments
    • 4.6 HVRI
      • 4.6.1 HVRI Company Information
      • 4.6.2 HVRI Description, Business Overview
      • 4.6.3 HVRI Veterinary Vaccine Products Offered
      • 4.6.4 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.6.5 HVRI Veterinary Vaccine Sales by Product in 2023
      • 4.6.6 HVRI Veterinary Vaccine Sales by Application in 2023
      • 4.6.7 HVRI Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.6.8 HVRI Recent Development
    • 4.7 Ringpu Biology
      • 4.7.1 Ringpu Biology Company Information
      • 4.7.2 Ringpu Biology Description, Business Overview
      • 4.7.3 Ringpu Biology Veterinary Vaccine Products Offered
      • 4.7.4 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.7.5 Ringpu Biology Veterinary Vaccine Sales by Product in 2023
      • 4.7.6 Ringpu Biology Veterinary Vaccine Sales by Application in 2023
      • 4.7.7 Ringpu Biology Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.7.8 Ringpu Biology Recent Development
    • 4.8 Yebio
      • 4.8.1 Yebio Company Information
      • 4.8.2 Yebio Description, Business Overview
      • 4.8.3 Yebio Veterinary Vaccine Products Offered
      • 4.8.4 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.8.5 Yebio Veterinary Vaccine Sales by Product in 2023
      • 4.8.6 Yebio Veterinary Vaccine Sales by Application in 2023
      • 4.8.7 Yebio Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.8.8 Yebio Recent Development
    • 4.9 DHN
      • 4.9.1 DHN Company Information
      • 4.9.2 DHN Description, Business Overview
      • 4.9.3 DHN Veterinary Vaccine Products Offered
      • 4.9.4 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.9.5 DHN Veterinary Vaccine Sales by Product in 2023
      • 4.9.6 DHN Veterinary Vaccine Sales by Application in 2023
      • 4.9.7 DHN Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.9.8 DHN Recent Development
    • 4.10 WINSUN
      • 4.10.1 WINSUN Company Information
      • 4.10.2 WINSUN Description, Business Overview
      • 4.10.3 WINSUN Veterinary Vaccine Products Offered
      • 4.10.4 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.10.5 WINSUN Veterinary Vaccine Sales by Product in 2023
      • 4.10.6 WINSUN Veterinary Vaccine Sales by Application in 2023
      • 4.10.7 WINSUN Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.10.8 WINSUN Recent Development
    • 4.11 Elanco
      • 4.11.1 Elanco Company Information
      • 4.11.2 Elanco Description, Business Overview
      • 4.11.3 Elanco Veterinary Vaccine Products Offered
      • 4.11.4 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.11.5 Elanco Veterinary Vaccine Sales by Product in 2023
      • 4.11.6 Elanco Veterinary Vaccine Sales by Application in 2023
      • 4.11.7 Elanco Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.11.8 Elanco Recent Development
    • 4.12 Virbac
      • 4.12.1 Virbac Company Information
      • 4.12.2 Virbac Description, Business Overview
      • 4.12.3 Virbac Veterinary Vaccine Products Offered
      • 4.12.4 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.12.5 Virbac Veterinary Vaccine Sales by Product in 2023
      • 4.12.6 Virbac Veterinary Vaccine Sales by Application in 2023
      • 4.12.7 Virbac Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.12.8 Virbac Recent Development
    • 4.13 Jinyu Bio-Technology
      • 4.13.1 Jinyu Bio-Technology Company Information
      • 4.13.2 Jinyu Bio-Technology Description, Business Overview
      • 4.13.3 Jinyu Bio-Technology Veterinary Vaccine Products Offered
      • 4.13.4 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.13.5 Jinyu Bio-Technology Veterinary Vaccine Sales by Product in 2023
      • 4.13.6 Jinyu Bio-Technology Veterinary Vaccine Sales by Application in 2023
      • 4.13.7 Jinyu Bio-Technology Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.13.8 Jinyu Bio-Technology Recent Development
    • 4.14 ChengDu Tecbond
      • 4.14.1 ChengDu Tecbond Company Information
      • 4.14.2 ChengDu Tecbond Description, Business Overview
      • 4.14.3 ChengDu Tecbond Veterinary Vaccine Products Offered
      • 4.14.4 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.14.5 ChengDu Tecbond Veterinary Vaccine Sales by Product in 2023
      • 4.14.6 ChengDu Tecbond Veterinary Vaccine Sales by Application in 2023
      • 4.14.7 ChengDu Tecbond Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.14.8 ChengDu Tecbond Recent Development
    • 4.15 CAVAC
      • 4.15.1 CAVAC Company Information
      • 4.15.2 CAVAC Description, Business Overview
      • 4.15.3 CAVAC Veterinary Vaccine Products Offered
      • 4.15.4 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.15.5 CAVAC Veterinary Vaccine Sales by Product in 2023
      • 4.15.6 CAVAC Veterinary Vaccine Sales by Application in 2023
      • 4.15.7 CAVAC Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.15.8 CAVAC Recent Development
    • 4.16 Kyoto Biken Laboratories
      • 4.16.1 Kyoto Biken Laboratories Company Information
      • 4.16.2 Kyoto Biken Laboratories Description, Business Overview
      • 4.16.3 Kyoto Biken Laboratories Veterinary Vaccine Products Offered
      • 4.16.4 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.16.5 Kyoto Biken Laboratories Veterinary Vaccine Sales by Product in 2023
      • 4.16.6 Kyoto Biken Laboratories Veterinary Vaccine Sales by Application in 2023
      • 4.16.7 Kyoto Biken Laboratories Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.16.8 Kyoto Biken Laboratories Recent Development
    • 4.17 FATRO
      • 4.17.1 FATRO Company Information
      • 4.17.2 FATRO Description, Business Overview
      • 4.17.3 FATRO Veterinary Vaccine Products Offered
      • 4.17.4 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.17.5 FATRO Veterinary Vaccine Sales by Product in 2023
      • 4.17.6 FATRO Veterinary Vaccine Sales by Application in 2023
      • 4.17.7 FATRO Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.17.8 FATRO Recent Development
    • 4.18 Vaksindo
      • 4.18.1 Vaksindo Company Information
      • 4.18.2 Vaksindo Description, Business Overview
      • 4.18.3 Vaksindo Veterinary Vaccine Products Offered
      • 4.18.4 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.18.5 Vaksindo Veterinary Vaccine Sales by Product in 2023
      • 4.18.6 Vaksindo Veterinary Vaccine Sales by Application in 2023
      • 4.18.7 Vaksindo Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.18.8 Vaksindo Recent Development
    • 4.19 Bio-Labs
      • 4.19.1 Bio-Labs Company Information
      • 4.19.2 Bio-Labs Description, Business Overview
      • 4.19.3 Bio-Labs Veterinary Vaccine Products Offered
      • 4.19.4 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.19.5 Bio-Labs Veterinary Vaccine Sales by Product in 2023
      • 4.19.6 Bio-Labs Veterinary Vaccine Sales by Application in 2023
      • 4.19.7 Bio-Labs Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.19.8 Bio-Labs Recent Development
    • 4.20 Avimex Animal Health
      • 4.20.1 Avimex Animal Health Company Information
      • 4.20.2 Avimex Animal Health Description, Business Overview
      • 4.20.3 Avimex Animal Health Veterinary Vaccine Products Offered
      • 4.20.4 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.20.5 Avimex Animal Health Veterinary Vaccine Sales by Product in 2023
      • 4.20.6 Avimex Animal Health Veterinary Vaccine Sales by Application in 2023
      • 4.20.7 Avimex Animal Health Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.20.8 Avimex Animal Health Recent Development
    • 4.21 MEVAC
      • 4.21.1 MEVAC Company Information
      • 4.21.2 MEVAC Description, Business Overview
      • 4.21.3 MEVAC Veterinary Vaccine Products Offered
      • 4.21.4 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.21.5 MEVAC Veterinary Vaccine Sales by Product in 2023
      • 4.21.6 MEVAC Veterinary Vaccine Sales by Application in 2023
      • 4.21.7 MEVAC Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.21.8 MEVAC Recent Development
    • 4.22 Biovac
      • 4.22.1 Biovac Company Information
      • 4.22.2 Biovac Description, Business Overview
      • 4.22.3 Biovac Veterinary Vaccine Products Offered
      • 4.22.4 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.22.5 Biovac Veterinary Vaccine Sales by Product in 2023
      • 4.22.6 Biovac Veterinary Vaccine Sales by Application in 2023
      • 4.22.7 Biovac Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.22.8 Biovac Recent Development
    • 4.23 Atafen
      • 4.23.1 Atafen Company Information
      • 4.23.2 Atafen Description, Business Overview
      • 4.23.3 Atafen Veterinary Vaccine Products Offered
      • 4.23.4 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.23.5 Atafen Veterinary Vaccine Sales by Product in 2023
      • 4.23.6 Atafen Veterinary Vaccine Sales by Application in 2023
      • 4.23.7 Atafen Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.23.8 Atafen Recent Development
    • 4.24 Dyntec
      • 4.24.1 Dyntec Company Information
      • 4.24.2 Dyntec Description, Business Overview
      • 4.24.3 Dyntec Veterinary Vaccine Products Offered
      • 4.24.4 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.24.5 Dyntec Veterinary Vaccine Sales by Product in 2023
      • 4.24.6 Dyntec Veterinary Vaccine Sales by Application in 2023
      • 4.24.7 Dyntec Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.24.8 Dyntec Recent Development
    • 4.25 RVSRI
      • 4.25.1 RVSRI Company Information
      • 4.25.2 RVSRI Description, Business Overview
      • 4.25.3 RVSRI Veterinary Vaccine Products Offered
      • 4.25.4 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.25.5 RVSRI Veterinary Vaccine Sales by Product in 2023
      • 4.25.6 RVSRI Veterinary Vaccine Sales by Application in 2023
      • 4.25.7 RVSRI Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.25.8 RVSRI Recent Development
    • 4.26 Medion
      • 4.26.1 Medion Company Information
      • 4.26.2 Medion Description, Business Overview
      • 4.26.3 Medion Veterinary Vaccine Products Offered
      • 4.26.4 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
      • 4.26.5 Medion Veterinary Vaccine Sales by Product in 2023
      • 4.26.6 Medion Veterinary Vaccine Sales by Application in 2023
      • 4.26.7 Medion Veterinary Vaccine Sales by Geographic Area in 2023
      • 4.26.8 Medion Recent Development

  • 5 Breakdown Data by Type

    • 5.1 Global Veterinary Vaccine Sales by Type (2019-2030)
      • 5.1.1 Global Veterinary Vaccine Sales by Type (2019-2024)
      • 5.1.2 Global Veterinary Vaccine Sales Forecast by Type (2025-2030)
      • 5.1.3 Global Veterinary Vaccine Sales Market Share by Type (2019-2030)
    • 5.2 Global Veterinary Vaccine Revenue Forecast by Type (2019-2030)
      • 5.2.1 Global Veterinary Vaccine Revenue by Type (2019-2024)
      • 5.2.2 Global Veterinary Vaccine Revenue Forecast by Type (2025-2030)
      • 5.2.3 Global Veterinary Vaccine Revenue Market Share by Type (2019-2030)
    • 5.3 Veterinary Vaccine Average Selling Price (ASP) by Type (2019-2030)

  • 6 Breakdown Data by Application

    • 6.1 Global Veterinary Vaccine Sales by Application (2019-2030)
      • 6.1.1 Global Veterinary Vaccine Sales by Application (2019-2024)
      • 6.1.2 Global Veterinary Vaccine Sales Forecast by Application (2025-2030)
      • 6.1.3 Global Veterinary Vaccine Sales Market Share by Application (2019-2030)
    • 6.2 Global Veterinary Vaccine Revenue Forecast by Application (2019-2030)
      • 6.2.1 Global Veterinary Vaccine Revenue by Application (2019-2024)
      • 6.2.2 Global Veterinary Vaccine Revenue Forecast by Application (2025-2030)
      • 6.2.3 Global Veterinary Vaccine Revenue Market Share by Application (2019-2030)
    • 6.3 Veterinary Vaccine Average Selling Price (ASP) by Application (2019-2030)

  • 7 North America

    • 7.1 North America Veterinary Vaccine Market Size YoY Growth 2019-2030
    • 7.2 North America Veterinary Vaccine Market Facts & Figures by Country
      • 7.2.1 North America Veterinary Vaccine Sales by Country (2019-2030)
      • 7.2.2 North America Veterinary Vaccine Revenue by Country (2019-2030)
    • 7.3 North America Veterinary Vaccine Sales by Type (2019-2024)
    • 7.4 North America Veterinary Vaccine Sales by Application (2019-2024)

  • 8 Asia-Pacific

    • 8.1 Asia-Pacific Veterinary Vaccine Market Size YoY Growth 2019-2030
    • 8.2 Asia-Pacific Veterinary Vaccine Market Facts & Figures by Region
      • 8.2.1 Asia-Pacific Veterinary Vaccine Sales by Region (2019-2030)
      • 8.2.2 Asia-Pacific Veterinary Vaccine Revenue by Region (2019-2030)
    • 8.3 Asia-Pacific Veterinary Vaccine Sales by Type (2019-2024)
    • 8.4 Asia-Pacific Veterinary Vaccine Sales by Application (2019-2024)

  • 9 Europe

    • 9.1 Europe Veterinary Vaccine Market Size YoY Growth 2019-2030
    • 9.2 Europe Veterinary Vaccine Market Facts & Figures by Country
      • 9.2.1 Europe Veterinary Vaccine Sales by Country (2019-2030)
      • 9.2.2 Europe Veterinary Vaccine Revenue by Country (2019-2030)
    • 9.3 Europe Veterinary Vaccine Sales by Type (2019-2024)
    • 9.4 Europe Veterinary Vaccine Sales by Application (2019-2024)

  • 10 Latin America

    • 10.1 Latin America Veterinary Vaccine Market Size YoY Growth 2019-2030
    • 10.2 Latin America Veterinary Vaccine Market Facts & Figures by Country
      • 10.2.1 Latin America Veterinary Vaccine Sales by Country (2019-2030)
      • 10.2.2 Latin America Veterinary Vaccine Revenue by Country (2019-2030)
    • 10.3 Latin America Veterinary Vaccine Sales by Type (2019-2024)
    • 10.4 Latin America Veterinary Vaccine Sales by Application (2019-2024)

  • 11 Middle East and Africa

    • 11.1 Middle East and Africa Veterinary Vaccine Market Size YoY Growth 2019-2030
    • 11.2 Middle East and Africa Veterinary Vaccine Market Facts & Figures by Country
      • 11.2.1 Middle East and Africa Veterinary Vaccine Sales by Country (2019-2030)
      • 11.2.2 Middle East and Africa Veterinary Vaccine Revenue by Country (2019-2030)
    • 11.3 Middle East and Africa Veterinary Vaccine Sales by Type (2019-2024)
    • 11.4 Middle East and Africa Veterinary Vaccine Sales by Application (2019-2024)

  • 12 Supply Chain and Sales Channel Analysis

    • 12.1 Veterinary Vaccine Supply Chain Analysis
    • 12.2 Veterinary Vaccine Key Raw Materials and Upstream Suppliers
    • 12.3 Veterinary Vaccine Clients Analysis
    • 12.4 Veterinary Vaccine Sales Channel and Sales Model Analysis
      • 12.4.1 Veterinary Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
      • 12.4.2 Veterinary Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
      • 12.4.3 Veterinary Vaccine Distributors

  • 13 Market Dynamics

    • 13.1 Veterinary Vaccine Industry Trends
    • 13.2 Veterinary Vaccine Market Drivers
    • 13.3 Veterinary Vaccine Market Challenges
    • 13.4 Veterinary Vaccine Market Restraints

  • 14 Research Findings and Conclusion

  • 15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details
    • 15.3 Disclaimer
USD 5,900 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.
Global Veterinary Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030 | Pharmaceutical_LifeSciense Market Research Report - ShareFair Markets